Recent efforts are aiming to promote the use and adoption of Adverse Outcome Pathways (AOPs) to demonstrate the safety of advanced materials and technologies such as nanomaterials.
Read MoreThe European Chemicals Agency (ECHA) recently updated its guidance on how to use non-animal testing methods to gather data for REACH substance registration.
Read More